Seoul, South Korea

Eunice Eun Kyeong Kim


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eunice Eun Kyeong Kim: Innovator in Anti-Virus Compounds

Introduction

Eunice Eun Kyeong Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with anti-viral properties. His work focuses on addressing critical health issues, such as those caused by the hepatitis C virus.

Latest Patents

Eunice holds a patent for a carbazole compound that exhibits anti-virus activity. This invention relates to a novel compound selected from a group of carbazole compounds that demonstrate excellent anti-proliferative efficacy against the hepatitis C virus (HCV). The patent also includes a pharmaceutically acceptable salt, a hydrate, and an isomer of the compound. Additionally, it covers an anti-virus pharmaceutical composition that incorporates this novel compound as an active ingredient, aimed at preventing or treating liver diseases caused by HCV, along with a method for preparing the compound.

Career Highlights

Eunice has worked with prestigious institutions, including the Korea Institute of Science and Technology and the Postech Academy-Industry Foundation. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Eunice has collaborated with esteemed colleagues such as Gyo Chang Keum and Sung Key Jang. Their joint efforts have furthered research in the field of anti-viral compounds.

Conclusion

Eunice Eun Kyeong Kim's innovative work in developing anti-viral compounds highlights his commitment to improving public health. His contributions are vital in the ongoing fight against viral infections, particularly hepatitis C.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…